[Federal Register Volume 67, Number 237 (Tuesday, December 10, 2002)]
[Notices]
[Pages 75862-75863]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-31072]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 5, 2001, and published in the Federal 
Register on October 17, 2001, (66 FR 52780), B.I. Chemicals, Inc. which 
changed its name to Boehringer Ingelheim Chemicals, Inc., 2820 N. 
Normandy Drive, Petersburg, Virginia 23805, made application by renewal 
to the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                             Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100)...........................................         II
Methadone (9250).............................................         II
Methadone-intermediate (9254)................................         II
Levo-alphacetylmethadol (9648)...............................         II
------------------------------------------------------------------------

    The firms plans to bulk manufacture the listed controlled 
substances for formulation into finished pharmaceuticals.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Boehringer Ingelheim Inc.

[[Page 75863]]

to manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated the firm on a 
regular basis to ensure that the company's continued registration is 
consistent with the public interest. These investigations have included 
inspection and testing of the company's physical security systems, 
audits of the company's records, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 
0.100 and 0.104, the Deputy Assistant Administrator, Office of 
Diversion Control, hereby orders that the application submitted by the 
above firm for registration as a bulk manufacturer of the basic classes 
of controlled substances listed above is granted.

    Dated: November 5, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-31072 Filed 12-9-02; 8:45 am]
BILLING CODE 4410-09-M